Structural Characterization of a Soluble Amyloid β-Peptide Oligomer
Authors:
- 13 February 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (9) , 1870-1877
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that is linked to the presence of amyloid β-peptides that can form insoluble fibrils or soluble oligomeric assemblies. Soluble forms are present in the brains and tissues of Alzheimer’s patients, and their presence correlates with disease progression. Long-lived soluble forms can be generated in vitro by using small amounts of aliphatic hydrocarbon chains of detergents or fatty acids in preparations of amyloid β-peptides. Using NMR, we have characterized soluble oligomers of Aβ preglobulomer and globulomer that are stable and alter synaptic activity. The NMR data indicate that these soluble forms have a mixed parallel and antiparallel β-sheet structure that is different from fibrils which contain only parallel β-sheets. Using the structural data, we engineered a disulfide bond into the soluble Aβ globulomer to give a “new” soluble antigen that is stable, homogeneous, and binds with the same affinity to selective antibodies as the parent wt globulomer.Keywords
This publication has 36 references indexed in Scilit:
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Amyloid pores from pathogenic mutationsNature, 2002
- Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?Trends in Neurosciences, 2001
- Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1999
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- Correlations of synaptic and pathological markers with cognition of the elderlyNeurobiology of Aging, 1995
- Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.Proceedings of the National Academy of Sciences, 1993
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991